STE STERIS plc
USHealthcareAs of 2026-07-09 14:52
Why STE matters now
STERIS plc (STE) is a US stock in Healthcare. The latest InvestLog snapshot shows $214.70 with +2.49% on the session and $20.92B in market capitalization; recent performance reads 1-month -5.51% and YTD -20.08%.
The latest financial table shown here is Q4 2026, with revenue of $1.59B, net income of $220.3M, and EPS of $2.24. Investors can compare that operating picture with valuation signals such as P/E 30.40 and FCF yield 4.9%.
The latest indexable market news headline is "Why Steris (STE) is a Top Growth Stock for the Long-Term" from Zacks Investment Research.
Additional event context on this page matters because analyst consensus is Buy with a median target of $269.50; recent insider activity includes Zangerle John Adam filing S-Sale; recent congressional disclosure data includes Gilbert Cisneros Purchase. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
30.40
PEG
0.59
P/B
2.76
P/S
3.33
EV/EBITDA
11.70
DCF Value
$271.41
FCF Yield
4.9%
Div Yield
1.2%
Margins & Returns
Gross Margin
44.2%
Operating Margin
18.6%
Net Margin
13.2%
ROE
11.1%
ROA
7.3%
ROIC
8.5%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2026 | $1.59B | $220.3M | $2.24 |
| FY 2026 | $5.94B | $785.1M | $7.93 |
| Q3 2026 | $1.50B | $192.8M | $1.96 |
| Q2 2026 | $1.46B | $191.9M | $1.94 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$269.50
Target (Median)
$269.50
Target Range
$269.00 - $270.00
Trading Activity
Insider Trades
Congress Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
0.92
STERIS plc operates as a global provider, delivering a wide array of products and services crucial for infection prevention and various procedural needs. The company's operations are strategically divided into four primary segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare division offers a comprehensive suite of solutions, encompassing specialized cleaning chemicals and sterility assurance products. It also provides automated systems for endoscope reprocessing and tracking, alongside critical capital equipment for sterile processing departments, such as washers, sterilizers, and accessories for gastrointestinal (GI) procedures. Additionally, this segment furnishes essential operating room equipment, including surgical tables, lighting, and connectivity solutions. Beyond products, the Healthcare division offers extensive support services, which include equipment management, installation, maintenance, upgrades, repairs, and troubleshooting for capital assets. It also delivers preventive maintenance programs, general repair services, and specialized instrument and endoscope repair. Furthermore, the division provides tailored consulting for process improvement and manages outsourced sterile processing services for instruments. The Applied Sterilization Technologies segment specializes in offering outsourced sterilization and testing services. These are provided to manufacturers of medical devices and pharmaceuticals through its expansive network of approximately 50 dedicated contract sterilization and laboratory facilities. In the Life Sciences sector, STERIS focuses on the design, production, and sale of consumable items. These include formulated cleaning chemistries, barrier and sterility assurance products, various sterilizers (both steam and vaporized hydrogen peroxide), and washer disinfectors. This segment also provides equipment installation, maintenance, upgrades, repairs, and troubleshooting, in addition to preventive maintenance programs. Finally, the Dental segment caters to dental practices by supplying a range of hand and powered dental instruments, infection control solutions, personal protective equipment (PPE), and products designed to maintain water quality within dental suites. STERIS's diverse portfolio of products and services reaches a broad clientele, including hospitals, other healthcare institutions, and pharmaceutical manufacturers. Established in 1985, STERIS plc maintains its corporate headquarters in Dublin, Ireland.